Registrars: | Capita Registrars |
CFO: | Gerald Desler |
Chief Executive Officer : | Mark Eccleston |
Executive Director: | Cathy Tralau-Stewart |
Executive Director: | Tralau Stewart |
Non-Executive Chairman: | Martin Gouldstone |
Non-Executive Dir: | Adrian de Courcey |
Address: | Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD |
Website: | http://www.valirx.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BLH13C52 |
Currency | UK Pounds |
Share Price | 1.68p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.25 |
52 Week Low | 1.23 |
Volume | 84,491 |
Shares Issued | 132.35m |
Market Cap | £2.22m |
RiskGrade | 435 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 3,649 @ 1.67p |
15:50 | 17,126 @ 1.60p |
13:42 | 1,000 @ 1.60p |
11:51 | 50,000 @ 1.68p |
11:46 | 11,414 @ 1.60p |
You are here: research